Tag
Delaying acellular dermal matrix (ADM) placement to the second-stage implant exchange in prepectoral 2-stage breast reconstruction reduces capsular contracture rates without increasing tissue expander loss, although seroma risk may rise in
A larger surface area of acellular dermal matrix relative to implant size significantly reduces capsular contracture risk following prepectoral implant-based breast reconstruction, with radiotherapy remaining a major risk factor.
Intraoperative isolation of autologous epidermal stem cells using Myseed technology improves vascularization, survival, and contraction rates of single-stage composite skin grafts in full-thickness wounds, offering a promising approach for
This report examines the ongoing association between industry payments and positive outcomes reported in acellular dermal matrix (ADM) studies following the 2021 FDA safety alert.
